Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933060 · ClinicalTrials.gov registry record · Phase 2
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
A Phase 2 study of Migraine Headache, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02933060: Completed Phase 2 study of Migraine Headache, sponsored by The Cooper Health System.
NCT02933060 is a Phase 2 study of Migraine Headache that has completed, run by The Cooper Health System. The registered enrollment target is 50 participants, below the 151-participant average among 6 other Migraine Headache trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02933060, a Phase 2 study of Migraine Headache, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether patients in the emergency department with migraine headache who are administered an intravenous fluid bolus will report greater improvement in pain scores than control patients.
Primary Outcome
The primary outcome will be the difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and one hour later, at completion of the intervention. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.
Conditions Studied
Interventions
- OTHER Control
- OTHER Normal saline (1000 mL)
Study Locations (1)
New Jersey
- Cooper Univeristy Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-09-28 |
| Phase | Phase 2 |
What the finished NCT02933060 record still lists
NCT02933060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 151-participant average among 6 other Migraine Headache trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Migraine Headache appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT02933060 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02933060 about?
NCT02933060 is a clinical study titled "Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache". The purpose of this study is to determine whether patients in the emergency department with migraine headache who are administered an intravenous fluid bolus will report greater improvement in pain scores than control patients.
What is the current status of trial NCT02933060?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2017-01. Estimated completion is 2017-09-28.
What conditions does trial NCT02933060 study?
This clinical trial studies the following conditions: Migraine Headache.
What interventions are being tested in trial NCT02933060?
The interventions under investigation include: Control (OTHER), Normal saline (1000 mL) (OTHER).
Who is sponsoring clinical trial NCT02933060?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02933060 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Light Exposure, Migraine Outcomes, and Sleep Quality
RECRUITING · NA
-
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
COMPLETED · NA
-
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
COMPLETED · NA
-
Efficacy, Tolerability, and Safety of DFN-15
COMPLETED · Phase 3
-
Greater Occipital Nerve Block for Migraine Prophylaxis
COMPLETED · Phase 4
-
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia